Clinical Research Unit / Clinical Pharmacology Unit

Clinical Research Units (CRUs) / Clinical Pharmacology Units (CPUs) provide the controlled environment and specialized infrastructure needed to conduct early-phase clinical trials, including first-in-human (FIH), bioavailability, and pharmacokinetic studies. These units are staffed by experienced medical professionals and equipped to ensure patient safety, regulatory compliance, and high-quality data collection. Service providers in this category support pharmaceutical and biotech sponsors by offering end-to-end capabilities—from protocol design and volunteer recruitment to dose administration and intensive pharmacological monitoring. By partnering with established CRUs/CPUs, sponsors can de-risk early development, accelerate timelines, and generate robust clinical data critical for regulatory decision-making.